Lab to Lives
autor: Ivanna Rosendal
Najnowszy odcinek
How To Turn Stalled Research Into Treatments For Ultra-Rare Diseases…
How To Turn Stalled Research Into Treatments For Ultra-Rare Diseases…
O tym podcaście
A simple question started this show: How do we medicine from the lab to making a difference in people's lives as quickly as possible?
The answers are complex. Actual solutions are hard to come by. We want to distill ideas until we see actual impact in the industry.
Our three hosts all have backgrounds in life sciences and in improv comedy. Together, with their guests, they're on a mission to have conversations that can have an impact. And have some fun along the way.
Odcinki
Najnowsze 20 z 104 odcinków
- How To Turn Stalled Research Into Treatments For Ultra-Rare Diseases w/ Stephanie Manton · 1 godz. 0 min · Sezon 8 Odcinek 12Send us Fan Mail A therapy can be scientifically obvious and still never reach a patient. That contradiction is the centre of our conversation with Stephanie, CEO of WinQure…
- Clinical Trials Move Faster When Sites Get Paid On Time · 49 min · Sezon 8 Odcinek 12Send us Fan Mail A clinical trial can have brilliant science and still stall for a painfully ordinary reason: the site does not get paid on time. We sit down with Patrick Mizer…
- Scaling Science Without Losing The Plot w/ Jennifer Man · 53 min · Sezon 8 Odcinek 11Send us Fan Mail 12 million samples at minus 80 is not a fun fact, it is a daily responsibility. We sit down with Jennifer Man, Scientific Director at UK Biocentre in Milton…
- If Your Medicine Arrives With A Screwdriver, It is Counterfeit w/ David Chametzky · 43 min · Sezon 8 Odcinek 10Send us Fan Mail A medicine can look perfect and still be wrong, and that gap between appearance and reality is where patients get hurt. We sit down with Dave Chametzky, who…
- Trailer · 1 minSend us Fan Mail Support the show ________ Reach out to Ivanna Rosendal Join the conversation on our LinkedIn page Visit www.labtolives.com Hosts Alexander Booth Chiara Chianese…
- Male Fertility in The Human Being Room w/ Chiara Chianese · 46 min · Sezon 8 Odcinek 9Send us Fan Mail If you have ever wondered why brilliant healthcare ideas still fail to reach patients, this conversation gets uncomfortably specific, in the best way. We sit…
- How Many Alexes Does It Take To Launch A Drug w/ Daphne Smyth · 40 minSend us Fan Mail Europe looks like one market on a map, but try bringing a drug across borders and you quickly learn it behaves like many systems at once. We sit down with Daphne…
- Pharma Wants A Cupcake But Gets Ingredients w/ Dr. Isabelle Widmer · 46 min · Sezon 8 Odcinek 7Send us Fan Mail Pharma doesn’t usually fail because the science is too hard. It stalls because humans are trying to do hard work inside a system that is overloaded, siloed and…
- Enabling Clinical Trial Technology that Cuts Risk and Speeds Patient Access · 44 min · Sezon 8 Odcinek 6Send us Fan Mail Clinical trials are meant to generate evidence, not paperwork, but too many studies still depend on spreadsheets, duplicate data entry and unconnected systems…
- The Emperor’s Naked And The Trial’s Still On w/ Dr. Grant Coren · 1 godz. 4 min · Sezon 8 Odcinek 5Send us Fan Mail “Patients first” sounds simple until you follow the incentives. We’re joined by Dr Grant Coren, a genetics-trained PhD who moved from cancer research into…
- What If The Real Blocker Is Coordination Not Data w/ Anastasia Christianson · 50 min · Sezon 8 Odcinek 4Send us Fan Mail AI is everywhere in pharma right now, yet drug development still feels slow, fragmented, and full of avoidable rework. We sit down with Anastasia Christianson…
- Electrifying the Factory: Agentic AI For Faster Clinical Trials with Pamela Tenaerts · 48 min · Sezon 8 Odcinek 3Send us Fan Mail The clinical trial system is starting to look like a motorway at a standstill: more and more drugs are lining up, but the lanes ahead are already full. We sit…
- Why Big Pharma Feels Like A Financial Institution & Don't Pee on Medical Gloves with Anish Shindore · 1 godz. 7 min · Sezon 8 Odcinek 2Send us Fan Mail A medicine can be proven safe and effective, approved by regulators, and still fail the one test that matters: actually reaching patients in the real world. We…
- How Biotech Ideas Become Real Patient Impact w/ new co-hosts Alex and Dimitri · 47 min · Sezon 8 Odcinek 1Send us Fan Mail This is the first episode in the rebranded show! Drug and medical device breakthroughs do not reach patients because they’re clever in a lab. They reach patients…
- Dear Pharma, Your Patient Isn’t A KPI with Mark Duman · 24 min · Sezon 7 Odcinek 10Send us Fan Mail What happens when we stop calling people “subjects” and start inviting them to help build the solutions they need? We sit down with pharmacist and patient…
- Audit Trails, RBQM, And Agentic AI Explained · 37 min · Sezon 7 Odcinek 9Send us Fan Mail Ever wondered why a clean CSR still leaves you unsure how a trial actually ran? We dive into the hidden layer that explains the “how”: audit trails across EDC…
- Why Bringing The Trial To The Patient Beats Dragging Patients To Sites · 19 min · Sezon 7 Odcinek 8Send us Fan Mail Want clinical research that respects real life? We sit down with Caroline Potts, GM of Site and Patient Services at MRN, to rethink how patients are recruited…
- Inside Sionna’s Bid To Normalize CFTR Function · 30 min · Sezon 7 Odcinek 7Send us Fan Mail Two leaders from Sionna Therapeutics walk through a 15‑year journey from Genzyme science to a public company advancing NBD1‑targeted therapies in cystic…
- AI Won’t Replace Writers, But Writers Who Use AI Will Outpace The Rest with Bilal Bham · 23 minSend us Fan Mail What if the documents behind a clinical trial were written with the patient’s voice in mind and delivered at the speed modern science deserves? We sit down with…
- From Grief To Global Advocacy For Clinical Research In Infectious Diseases with Christian John Lillis · 29 minSend us Fan Mail A routine dental visit, a few days of diarrhea, and then the unthinkable: septic shock and a life lost within 24 hours. Our guest, Christian John Lillis, shares…
